Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
nMXBb8JktBErJyYJ
